{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:45:45Z","timestamp":1778899545209,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.ijantimicag.2010.02.007","type":"journal-article","created":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T06:52:44Z","timestamp":1269327164000},"page":"544-549","source":"Crossref","is-referenced-by-count":12,"title":["Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by \u03b2-lactam-susceptible and highly resistant pneumococci"],"prefix":"10.1016","volume":"35","author":[{"given":"Violeta","family":"Rodr\u00edguez-Cerrato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"del Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Huelves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pl\u00ednio","family":"Naves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Ponte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2010.02.007_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-97","volume":"90","author":"Feikin","year":"2000","journal-title":"Am J Public Health"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2010.02.007_bib2","first-page":"ii105","article-title":"BSAC Working Parties on Resistance Surveillance. Clinical implications of antimicrobial resistance for therapy","volume":"62","author":"MacGowan","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib3","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/500140","article-title":"The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis","volume":"42","author":"Tleyjeh","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib4","first-page":"110","article-title":"Pneumococcal vaccines","volume":"78","author":"World Health Organization","year":"2003","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib5","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/AAC.26.6.933","article-title":"Susceptibility of multiply antibiotic-resistant pneumococci to the new quinoline antibiotics, nalidixic acid, coumermycin, and novobiocin","volume":"26","author":"Gombert","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0732-8893(89)90105-3","article-title":"Should novobiocin be clinically re-evaluated?","volume":"12","author":"Jones","year":"1989","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib7","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AAC.47.3.869-877.2003","article-title":"Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin","volume":"47","author":"Schmutz","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib8","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1073\/pnas.75.10.4838","article-title":"Energy coupling in DNA gyrase and the mechanism of action of novobiocin","volume":"75","author":"Sugino","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib9","first-page":"277","article-title":"Novobiocin, a new antibiotic; laboratory and clinical evaluation of thirty patients with bacterial pneumonia","volume":"2","author":"Limson","year":"1956","journal-title":"Antibiotic Med Clin Ther"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0022-3476(57)80222-4","article-title":"Serious reactions to novobiocin","volume":"50","author":"Bridges","year":"1957","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM195907162610307","article-title":"Novobiocin jaundice","volume":"261","author":"Cox","year":"1959","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib12","first-page":"241","article-title":"Novobiocin; a limited bacteriologic and clinical study of its use in forty-five patients","volume":"2","author":"Nichols","year":"1956","journal-title":"Antibiotic Med Clin Ther"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib13","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement Document M100-S18. Wayne, PA: CLSI; 2008."},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1099\/ijs.0.02372-0","article-title":"Reclassification of ATCC 9341 from Micrococcus luteus to Kocuria rhizophila","volume":"53","author":"Tang","year":"2003","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib15","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1086\/595857","article-title":"Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004\u20132005","volume":"48","author":"Richter","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1128\/AAC.01324-08","article-title":"In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae","volume":"53","author":"McGee","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/mdr.1995.1.71","article-title":"Novel penicillin-resistant clones of Streptococcus pneumoniae in the Czech Republic and in Slovakia","volume":"1","author":"S\u00e1 Figueiredo","year":"1995","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib18","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/jac\/dkn392","article-title":"Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin\/cefotaxime MICs of 16mg\/L and their genotypic and geographical relatedness","volume":"62","author":"Soriano","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib19","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1128\/AAC.34.9.1655","article-title":"Efficacy of short courses of oral novobiocin\u2013rifampin in eradicating carrier state of methicillin-resistant Staphylococcus aureus and in vitro killing studies of clinical isolates","volume":"34","author":"Arathoon","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib20","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/AAC.37.6.1334","article-title":"Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim\u2013sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome","volume":"37","author":"Walsh","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib21","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/AAC.39.3.794","article-title":"Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium","volume":"39","author":"Montecalvo","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib22","first-page":"51","article-title":"Novobiocin, a new antibiotic","volume":"75","author":"Shane","year":"1956","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/AAC.30.1.42","article-title":"Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combination","volume":"30","author":"Drusano","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib24","first-page":"27","article-title":"A study of the sensitizing potential of novobiocin","volume":"3","author":"Welch","year":"1956","journal-title":"Antibiotic Med Clin Ther"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib25","first-page":"510","article-title":"A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity","volume":"51","author":"Eder","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jac\/38.2.227","article-title":"Correlation of in-vitro activity and pharmacokinetic parameters with in-vivo effect of amoxycillin, co-amoxiclav and cefotaxime in a murine model of pneumococcal pneumonia","volume":"38","author":"Soriano","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib27","series-title":"Goodman and Gilman's the pharmacological basis of therapeutics","first-page":"1115","article-title":"Penicillins, cephalosporins, and other \u03b2-lactam antibiotics","author":"Mandell","year":"1985"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib28","first-page":"230","article-title":"Penicillins","volume":"vol. 1","author":"Neu","year":"1985"},{"key":"10.1016\/j.ijantimicag.2010.02.007_bib29","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1128\/jb.177.14.4166-4170.1995","article-title":"Ser-127-to-Leu substitution in the DNA gyrase B subunit of Streptococcus pneumoniae is implicated in novobiocin resistance","volume":"177","author":"Mu\u00f1oz","year":"1995","journal-title":"J Bacteriol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910000816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910000816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T04:28:06Z","timestamp":1544588886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857910000816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0924857910000816"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.02.007","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}